| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 0.800 +3.12% on 05/27/25 | | 0.900 -8.33% on 05/13/25 | +0.003 (+0.36%) since 04/25/25 |
| 3-Month | 0.721 +14.42% on 04/17/25 | | 1.500 -45.00% on 03/18/25 | -0.575 (-41.07%) since 02/27/25 |
| 52-Week | 0.721 +14.42% on 04/17/25 | | 2.100 -60.71% on 01/16/25 | -0.675 (-45.00%) since 05/24/24 |
Patented Artificial Intelligence Technology Eliminates the Need for Gadolinium-Based Contrast Agents in MRI Exams
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
MILWAUKEE, WI / ACCESSWIRE / March 10, 2022 / IQ-AI Limited (OTCQB:IQAIF) (LSE:IQAI) is pleased to announce that the sponsored Phase I clinical trial for oral gallium maltolate (GaM) is open for enrollment....
Imaging Biometrics, a subsidiary of IQ-AI Limited (OTCQB:IQAIF) (LSE:IQAI), discusses its most successful year on record. - Increases technology platform and expects record revenues - Rolls out Phase I...
IB Zero G™ Technology May Benefit Imaging in Pediatric Patients MILWAUKEE, WI / ACCESSWIRE / November 11, 2021 / IQ-AI Limited (OTCQB:IQAIF) (LSE:IQAI), a developer of medical image processing platforms...
Installation Includes IB Neuro™ and IB DCE™ Software Purchase also Includes IB Clinic - Mac Edition MILWAUKEE, WI / ACCESSWIRE / November 2, 2021 / IQ-AI Limited (LSE:IQAI)(OTCQB:IQAIF), a developer...
Company Enjoys Most Successful Year on Record Marked Increase in Revenue and Growing Technology Portfolio Sponsorship of a Phase I Clinical Trial MILWAUKEE, WI / ACCESSWIRE / October 28, 2021 / IQ-AI Limited...
Affiliated Hospital Purchases IB Clinic for Automated Analysis MILWAUKEE, WI / ACCESSWIRE / October 1, 2021 / IQ-AI Limited (LSE:IQAI) (OTCQB:IQAIF), a developer and manufacturer of medical image processing...
Affiliated Hospital Purchases IB Clinic for Automated Analysis MILWAUKEE, WI / ACCESSWIRE / October 1, 2021 / IQ-AI Limited (LSE:IQAI) (OTCQB:IQAIF), a developer and manufacturer of medical image processing...
MILWAUKEE, WI / ACCESSWIRE / September 22, 2021 / IQ-AI Limited (LSE:IQAI) (OTCQB:IQAIF), a developer and manufacturer of medical image processing platforms that have led to effective therapeutic strategies...
| 3rd Resistance Point | 0.875 |
| 2nd Resistance Point | 0.855 |
| 1st Resistance Point | 0.840 |
| Last Price | 0.825 |
| 1st Support Level | 0.805 |
| 2nd Support Level | 0.785 |
| 3rd Support Level | 0.770 |
| 52-Week High | 2.100 |
| Fibonacci 61.8% | 1.573 |
| Fibonacci 50% | 1.410 |
| Fibonacci 38.2% | 1.248 |
| Last Price | 0.825 |
| 52-Week Low | 0.721 |